PKD1 and pancreatic neoplasm: In conclusion, the inhibition of PKD1 by using pharmacological agents and small-interfering RNA/microRNA-mediated techniques can selectively suppress pancreatic tumour growth and metastasis via inhibition of glycolytic influx in PDAC cells.